Milestone Scientific (MLSS)
(Delayed Data from AMEX)
$0.56 USD
-0.01 (-1.75%)
Updated Apr 26, 2024 03:58 PM ET
After-Market: $0.57 +0.01 (1.79%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMPrice, Consensus and EPS Surprise
MLSS 0.56 -0.01(-1.75%)
Will MLSS be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for MLSS based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for MLSS
Milestone Scientific, Inc. (MLSS) Reports Q3 Loss, Lags Revenue Estimates
MLSS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for MLSS
Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables within PRC Alliance Pain Relief Center in Ormond Beach, Florida
Milestone Scientific commences sales of CompuFlo Epidural Disposables in Florida
Milestone Scientific: A Strong Buy on Robust Financials and Market Expansion Potential
MLSS Stock Earnings: Milestone Scientific Misses Revenue for Q4 2023
Milestone Scientific GAAP EPS of -$0.10, revenue of $9.83M